Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Rybinska I, Mangano N, Tagliabue E, Triulzi T
Under valuation model assumptions realized through 12/31/28, the stock is modeled using: Revenue growth (CAGR): 15.9% Operating Margins: 4.5% Exit P/E Multiple: 24.7x Based on these inputs, the model estimates a target price of $33, implying 17.7% total upside from the current share price of $28 and a 6.3% annualized return over the next 2.7 years
Our clinic is based in Scarsdale, New York, and eligible patients can also begin care through telehealth across New York, New Jersey, Connecticut, Florida, and California
Ozempic and Mounjaro: What Sets Them Apart Ozempic (semaglutide) and Mounjaro (tirzepatide) are the two front-runners fueling the GLP-1 Revolution
Rybelsus (oral semaglutide), for example, requires taking it on an empty stomach with no more than 4 ounces of water, then waiting at least 30 minutes before eating, drinking, or taking other medications
